Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series. Dermatology Reports, [S. l.], 2025. DOI: 10.4081/dr.2025.10379. Disponível em: https://journals.pagepress.org/dr/article/view/10379. Acesso em: 4 aug. 2025.